Cargando…
Control of MSSA and MRSA in the United States: protocols, policies, risk adjustment and excuses
Data released by the U.S. Centers for Disease Control and Prevention (CDC) on March 5, 2019 showed that Staph aureus infections are a major problem in the United States, with 119,000 infections and almost 20,000 deaths in 2017. Rates of decline for hospital-onset MRSA have slowed since 2012 and the...
Autor principal: | Kavanagh, Kevin T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582558/ https://www.ncbi.nlm.nih.gov/pubmed/31244994 http://dx.doi.org/10.1186/s13756-019-0550-2 |
Ejemplares similares
-
Applying Brown and Savulescu: the diachronic condition as excuse
por: Levy, Neil
Publicado: (2019) -
193. Comparison of Survival for MSSA and MRSA Endocarditis
por: Kanyo, Emese, et al.
Publicado: (2019) -
Proteomic profiling of the endogenous peptides of MRSA and MSSA
por: Tu, Haixia, et al.
Publicado: (2021) -
Amyloid Ion Channels: A Porous Argument or a Thin Excuse?
por: Eliezer, David
Publicado: (2006) -
Pyrazolyl Thioureas and Carbothioamides with an NNSN
Motif against MSSA and MRSA
por: Delpe-Acharige, Anjana, et al.
Publicado: (2021)